Evidence map›Paper›PMID 17638084›Full record

ReviewReviews in endocrine & metabolic disorders2007

Epigenetic reprogramming and imprinting in origins of disease.

Wan-yee Tang, Shuk-mei Ho

Abstract readReview
In one paragraph

Review in Reviews in endocrine & metabolic disorders, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 261 citations in OpenAlex.

  1. The association between bisphenol A exposure and type-2 diabetes: a world systematic review.Environmental science and pollution research international · 2016
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Epigenetic regulation of bone mass.Best practice & research. Clinical endocrinology & metabolism · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Wan-yee TangDepartment of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, OH, USA. tangwy@uc.edu
Shuk-mei Ho
University of Cincinnati · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI PINNEY, SUSAN MENGEL · 1992 to 2022
$35.4M
Windows of Susceptibility to PAH/DEP Exposure and AsthmaP50ES015905 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PERERA, FREDERICA P · 2007 to 2011
$10.3M
Epigenetic Basis for Prostate Carcinogenesis following Early Estrogenic ExposuresR01ES015584 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HO, SHUK-MEI, PRINS, GAIL S · 2008 to 2012
$3.1M
Development Modulation of Mouse Uterine TumorigenesisR21ES013071 · NIEHS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HO, SHUK-MEI · 2004 to 2006
$462k
ESTROGEN IMPRINTING OF PROSTATE GLAND VIA METHYLATONR21ES012281 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PRINS, GAIL S · 2003 to 2005
$398k
Estrogens/Xenoestrogens and Epigenetic Regulation of Gene ExpressionK99ES016817 · NIEHS · UNIVERSITY OF CINCINNATI · PI TANG, WAN-YEE · 2008 to 2009
$180k
NIEHS NIH HHS ES12281NIEHS NIH HHS ES13071NIEHS NIH HHS ES15584NIEHS NIH HHS ES15905NIEHS NIH HHS K99 ES016817NIEHS NIH HHS P30 ES006096NIEHS NIH HHS P50 ES015905NIEHS NIH HHS R01 ES015584NIEHS NIH HHS R21 ES012281NIEHS NIH HHS R21 ES013071
6 · The paper itself

Abstract

The traditional view that gene and environment interactions control disease susceptibility can now be expanded to include epigenetic reprogramming as a key determinant of origins of human disease. Currently, epigenetics is defined as heritable changes in gene expression that do not alter DNA sequence but are mitotically and transgenerationally inheritable. Epigenetic reprogramming is the process by which an organism's genotype interacts with the environment to produce its phenotype and provides a framework for explaining individual variations and the uniqueness of cells, tissues, or organs despite identical genetic information. The main epigenetic mediators are histone modification, DNA methylation, and non-coding RNAs. They regulate crucial cellular functions such as genome stability, X-chromosome inactivation, gene imprinting, and reprogramming of non-imprinting genes, and work on developmental plasticity such that exposures to endogenous or exogenous factors during critical periods permanently alter the structure or function of specific organ systems. Developmental epigenetics is believed to establish "adaptive" phenotypes to meet the demands of the later-life environment. Resulting phenotypes that match predicted later-life demands will promote health, while a high degree of mismatch will impede adaptability to later-life challenges and elevate disease risk. The rapid introduction of synthetic chemicals, medical interventions, environmental pollutants, and lifestyle choices, may result in conflict with the programmed adaptive changes made during early development, and explain the alarming increases in some diseases. The recent identification of a significant number of epigenetically regulated genes in various model systems has prepared the field to take on the challenge of characterizing distinct epigenomes related to various diseases. Improvements in human health could then be redirected from curative care to personalized, preventive medicine based, in part, on epigenetic markings etched in the "margins" of one's genetic make-up.

Indexed as

AcetylationAnimalsDisease SusceptibilityDNA MethylationEpigenesis, GeneticGenetic Predisposition to DiseaseGenomic ImprintingHistonesHumansModels, BiologicalHistones

Identifiers

PMID17638084
PMCPMC4056338
OpenAlexW2091101545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.